XML 16 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 28, 2018
Dec. 29, 2017
Current assets:    
Cash and cash equivalents $ 353,623 $ 183,164 [1]
Short-term investments 281,000 204,607 [1]
Short-term restricted cash and investments 504 504 [1]
Trade and other receivables 104,634 81,192 [1]
Inventory, net 10,433 6,657 [1]
Unbilled collaboration revenue 24,489 0 [1]
Prepaid expenses and other current assets 12,279 8,750 [1]
Total current assets 786,962 484,874 [1]
Long-term investments 114,093 64,255 [1]
Long-term restricted cash and investments 1,100 4,646 [1]
Property and equipment, net 51,046 25,743 [1]
Goodwill 63,684 63,684 [1]
Operating lease right-of-use assets 5,989 0 [1]
Other long-term assets 1,492 12,092 [1]
Total assets 1,024,366 655,294 [1]
Current liabilities:    
Accounts payable 8,679 9,575 [1]
Accrued compensation and benefits 27,283 21,073 [1]
Accrued clinical trial liabilities 18,958 19,849 [1]
Rebates and fees due to customers 11,689 7,565 [1]
Accrued collaboration liabilities 8,397 8,974 [1]
Current portion of deferred revenue 0 31,984 [1]
Other current liabilities 15,900 16,150 [1]
Total current liabilities 90,906 115,170 [1]
Long-term portion of deferred revenue 2,268 238,520 [1]
Long-term portion of lease liabilities 12,619  
Long-term portion of lease liabilities [1]   14,530
Other long-term liabilities 2,607 2,113 [1]
Total liabilities 108,400 370,333 [1]
Commitments [1]
Stockholders’ equity    
Preferred stock, $0.001 par value, 10,000,000 shares authorized and no shares issued 0 0 [1]
Common stock, $0.001 par value; 400,000,000 shares authorized; issued and outstanding: 295,700,576 and 289,923,798 at September 30, 2017 and December 31, 2016, respectively 299 296 [1]
Additional paid-in capital 2,156,632 2,114,184 [1]
Accumulated other comprehensive loss (513) (347) [1]
Accumulated deficit (1,240,452) (1,829,172) [1]
Total stockholders’ equity 915,966 284,961 [1]
Total liabilities and stockholders’ equity $ 1,024,366 $ 655,294 [1]
[1] The Condensed Consolidated Balance Sheet as of December 31, 2017 has been derived from the audited financial statements as of that date.